Blogs by 360biolabs Experts
Deep dive into our updates, capabilities and 10 year series
Select your interests:
Integrated Bioanalysis for Cell Therapy Oncology: A 360biolabs Case Study in Decision-Ready Data
1 September, 2026
Inside the bioanalysis strategy for a Phase 1/2a early oncology development program, with PK, ADA, immunophenotyping and molecular testing.
360biolabs: Integrated Bioanalysis for Complex Early-Phase Studies
8 July, 2026
How integrated PK, PD, immunogenicity, biomarker, flow cytometry, PBMC processing and central laboratory support help early-phase sponsors.
